1. Monitoring of complement activation biomarkers and eculizumab in complement‐mediated renal disorders. (25th November 2016) Authors: Wehling, C.; Amon, O.; Bommer, M.; Hoppe, B.; Kentouche, K.; Schalk, G.; Weimer, R.; Wiesener, M.; Hohenstein, B.; Tönshoff, B.; Büscher, R.; Fehrenbach, H.; Gök, Ö.‐N.; Kirschfink, M. Journal: Clinical and experimental immunology Issue: Volume 187:Number 2(2017:Feb.) Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗